EURAL GORDON: Open Payments
NPI 1174657514 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$670 in 11 payments from 9 companies in 2025. Trend: 2023 $734 · 2024 $559 · 2025 $670
Food & beverage: $670
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $195 |
| ABIOMED | 1 | $142 |
| AstraZeneca Pharmaceuticals LP | 2 | $135 |
| Medtronic, Inc. | 1 | $90 |
| PFIZER INC. | 1 | $32 |
| Novo Nordisk Inc | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| Sage Therapeutics, LLC | 1 | $14 |
Products named: AIRSUPRA, MOUNJARO, VENASEAL, JARDIANCE, PREVNAR 20, Wegovy, CAPLYTA, Dexcom G6 Transmitter.
Industry payments across CA — which companies pay providers there.
